Marathon Trading Investment Management LLC Fulcrum Therapeutics, Inc. Transaction History

Marathon Trading Investment Management LLC

$201 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 12, 2024	SELL	$5.98 - $9.31 $204,516 - $318,402	-34,200 Reduced 76.0%	10,800 $66,000
Q1 2024 May 10, 2024	BUY	$6.7 - $12.0 $301,500 - $540,000	45,000 New	45,000 $424,000

Others Institutions Holding FULC

# of Institutions

150

Shares Held

52.2M

Call Options Held

6.91M

Put Options Held

1.9M

Ra Capital Management, L.P. Boston, MA

10.2M
Shares

$30.6 Million
0.51% of portfolio
Tcg Crossover Management, LLC Palo Alto, CA

5.25M
Shares

$15.7 Million
2.43% of portfolio
Black Rock Inc. New York, NY

4.8M
Shares

$14.3 Million
0.0% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

4.78M
Shares

$14.3 Million
1.01% of portfolio
Vanguard Group Inc Valley Forge, PA

3.27M
Shares

$9.79 Million
0.0% of portfolio

View Full List

About Fulcrum Therapeutics, Inc.

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $156M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

More about FULC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.

Account